Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alamar Biosciences, Inc. (ALMR : NSDQ)

• Company Description    - Number of Employees: 222

• Price / Volume Information    Yesterday's Closing Price: $25.88 Daily Weekly Monthly 20 Day Moving Average: 369,232 shares Shares Outstanding: 69.31 (millions) Market Capitalization: $1,793.77 (millions) Beta: 52 Week High: $29.43 52 Week Low: $18.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.68% -4.39% 12 Week 3.35% 0.52% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 47071 BAYSIDE PARKWAY - FREMONT,CA 94538 USA ph: 510-626-9888 fax: 510-605-5062 investors@alamarbio.com https://alamarbio.com

• General Corporate Information    Officers Yuling Luo - Chief Executive Officer and Chairman Timothy Tod White - President Shiping Steve Chen - Chief Operating Officer and Director Justin McAnear - Chief Financial Officer Rebecca Chambers - Director Peer Information Alamar Biosciences, Inc. (CORR.) Alamar Biosciences, Inc. (RSPI) Alamar Biosciences, Inc. (CGXP) Alamar Biosciences, Inc. (BGEN) Alamar Biosciences, Inc. (GTBP) Alamar Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 010911105 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/10/26 Share - Related Items Shares Outstanding: 69.31 Most Recent Split Date: (:1) Beta: Market Capitalization: $1,793.77 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.22 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.42 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 98.88% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - 5.88 12/31/25 - 3.99 Quick Ratio 06/30/26 - - 03/31/26 - 4.22 12/31/25 - 2.37 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - -39.28 Book Value 06/30/26 - - 03/31/26 - -2.68 12/31/25 - - Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - 1.69 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 56.84 12/31/25 - 11.43

Powered by Zacks Investment Research ©